Cargando…
Cell-type-specific immune dysregulation in severely ill COVID-19 patients
Autores principales: | Yao, Changfu, Bora, Stephanie A., Parimon, Tanyalak, Zaman, Tanzira, Friedman, Oren A., Palatinus, Joseph A., Surapaneni, Nirmala S., Matusov, Yuri P., Chiang, Giuliana Cerro, Kassar, Alexander G., Patel, Nayan, Green, Chelsi E.R., Aziz, Adam W., Suri, Harshpreet, Suda, Jo, Lopez, Andres A., Martins, Gislâine A., Stripp, Barry R., Gharib, Sina A., Goodridge, Helen S., Chen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009498/ https://www.ncbi.nlm.nih.gov/pubmed/33789116 http://dx.doi.org/10.1016/j.celrep.2021.108943 |
Ejemplares similares
-
Cell type-specific immune dysregulation in severely ill COVID-19 patients
por: Yao, Changfu, et al.
Publicado: (2020) -
Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients
por: Yao, Changfu, et al.
Publicado: (2021) -
Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers
por: Cerro Chiang, Giuliana, et al.
Publicado: (2023) -
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
por: Parimon, Tanyalak, et al.
Publicado: (2020) -
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
por: Parimon, Tanyalak, et al.
Publicado: (2021)